l General Information |
Product Name | CCG-1423 |
General description | CCG-1423 is a specific RhoA pathway inhibitor, which inhibits SRF-mediated transcription. |
Synonym | N-[1-(4-chloroanilino)-1-oxopropan-2-yl]oxy-3,5-bis(trifluoromethyl)benzamide |
Purity | ≥98.5%(HPLC) | CAS Number | 285986-88-1 |
Formula | C18H13ClF6N2O3 | Molecular Weight | 454.75 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to beige Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | Slightly soluble |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
